MiniMed Launches Abbott's Instinct Sensors Across European Markets

Zacks Investment Research·24 Jun 2026·Read original

2▲2 ▼0Impact / 5

Product / Tech Health Care Equipment & Supplies

Summary · why it matters

MiniMed has commercially launched its MiniMed 780G automated insulin delivery system integrated with Abbott Laboratories' Instinct sensor and the MiniMed Go system integrated with the Instinct Go sensor across Europe. The rollout expands the company's sensor portfolio in the region and provides people with diabetes greater flexibility and choice in managing their condition. The MiniMed 780G system can now be paired with Abbott's Instinct sensor, a 15-day continuous glucose monitoring sensor marketed as the world's smallest, thinnest and most discreet sensor, while the MiniMed Go platform integrates the InPen smart insulin pen with the Instinct Go sensor through a single mobile application. A recent randomized crossover study demonstrated that glycemic outcomes were virtually identical when the 780G system was used with either the Instinct sensor or the company's Simplera Sync sensor, highlighting the strength of the platform's underlying algorithm. Shares of MiniMed have traded flat since the announcement on Wednesday, and in the year-to-date period the stock has lost 25.7 percent compared with the industry's 7.8 percent decline.

MiniMed Group, Inc. Common Stock ▲

Abbott Laboratories ▲